Cargando…

Oral Delivery of Biologics via the Intestine

Biologics are currently one of the most promising avenues for therapeutic interventions in conditions such as metabolic disease, ageing and inflammatory disorders, and for chronic ailments, oral delivery of such medicines has for years been recognised as an important goal. Despite decades of intensi...

Descripción completa

Detalles Bibliográficos
Autor principal: New, Roger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824380/
https://www.ncbi.nlm.nih.gov/pubmed/33374222
http://dx.doi.org/10.3390/pharmaceutics13010018
_version_ 1783640063157993472
author New, Roger
author_facet New, Roger
author_sort New, Roger
collection PubMed
description Biologics are currently one of the most promising avenues for therapeutic interventions in conditions such as metabolic disease, ageing and inflammatory disorders, and for chronic ailments, oral delivery of such medicines has for years been recognised as an important goal. Despite decades of intensive research, oral delivery of biologics is only just starting to prove feasible. There has been much talk about the barriers to uptake of biologics, and indeed, one function of the intestine is to prevent, in one way or another, passage of unwanted materials across the gut, and yet, grams of biological agents both large and small pass across the intestinal cell wall every day. This review first describes the functioning of the gut under normal circumstances, then identifies the principle biological mechanisms which have been harnessed successfully, to date, to achieve oral uptake, outlining the pros and cons of each approach. Examples with different biologics are given, and information on result of the latest clinical trials is provided, where available.
format Online
Article
Text
id pubmed-7824380
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-78243802021-01-24 Oral Delivery of Biologics via the Intestine New, Roger Pharmaceutics Review Biologics are currently one of the most promising avenues for therapeutic interventions in conditions such as metabolic disease, ageing and inflammatory disorders, and for chronic ailments, oral delivery of such medicines has for years been recognised as an important goal. Despite decades of intensive research, oral delivery of biologics is only just starting to prove feasible. There has been much talk about the barriers to uptake of biologics, and indeed, one function of the intestine is to prevent, in one way or another, passage of unwanted materials across the gut, and yet, grams of biological agents both large and small pass across the intestinal cell wall every day. This review first describes the functioning of the gut under normal circumstances, then identifies the principle biological mechanisms which have been harnessed successfully, to date, to achieve oral uptake, outlining the pros and cons of each approach. Examples with different biologics are given, and information on result of the latest clinical trials is provided, where available. MDPI 2020-12-24 /pmc/articles/PMC7824380/ /pubmed/33374222 http://dx.doi.org/10.3390/pharmaceutics13010018 Text en © 2020 by the author. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
New, Roger
Oral Delivery of Biologics via the Intestine
title Oral Delivery of Biologics via the Intestine
title_full Oral Delivery of Biologics via the Intestine
title_fullStr Oral Delivery of Biologics via the Intestine
title_full_unstemmed Oral Delivery of Biologics via the Intestine
title_short Oral Delivery of Biologics via the Intestine
title_sort oral delivery of biologics via the intestine
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7824380/
https://www.ncbi.nlm.nih.gov/pubmed/33374222
http://dx.doi.org/10.3390/pharmaceutics13010018
work_keys_str_mv AT newroger oraldeliveryofbiologicsviatheintestine